1. How Advocacy can Influence Pricing & Policy
Jessica Burry
HIV/HCV Pharmacist
July 2017

2. MSF and Access to Medicines
Médecins Sans Frontières (MSF), founded in 1971, is an international, independent, medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare in nearly 70 countries.

3. MSF and Access to Medicines
Life saving essential medicines
are either:
Unaffordable
Unavailable
Unsuitable

4. What’s the Goal?
Source: MSF Untangling the Web of Antiretroviral Price Reductions, 15th Edition, July 2012

5. Today: Still Unaffordable
HIV: the price of a third-line regimen is more than 17 times higher than the recommended first-line
Source: MSF Untangling the Web of antiretroviral Price Reductions, 18th Edition, July 2016

6. What are the Challenges?
High price of ARVs?
Intellectual Property (IP) barriers?
Lack of suppliers in the market?
Lack of generic competition?
Small volumes in the market?
Lack of transparancy :
$ of R&D?
$ of production?

7. What are the Challenges?
High cost of Medicines?
Intellectual Property (IP) barriers?
Patent Analysis
Patent Oppositions
Dolutegravir

8. What are the Challenges?
High cost of ARVs?
Intellectual Property (IP) barriers?
Patent Analysis
Patent Oppositions
Voluntary Licenses
Compulsory Licenses
E ‘t Hoen. Private Patents and Public Health: Changing intellectual property rules for access to medicines

9. What are the Challenges?
High cost of ARVs??
Lack of suppliers in the market?
Lack of generic competition?
Small volumes in the market?

10. What are the Challenges?
High cost of ARVs?
Lack of transparancy
$ of R&D?
$ of production?
$ of ARVs in other countries?

11. Tools & Communication

12. Communication

13. Communication

14. More Info! Waiting Isn’t An Option:
HIV & Opportunistic Infection Treatment: Spotlight on Access Gaps:
Waiting Isn’t An Option:

15. Merci! Thanks! @jessburry @MSF_Access www.msfaccess.org